Delving into the Latest Updates on Shanxi Fushenggong Pharmaceutical Group Co., Ltd. with Synapse

Overview

Tags

Cardiovascular Diseases

Congenital Disorders

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Hemic and Lymphatic Diseases	1
Infectious Diseases	1
Immune System Diseases	1
Nervous System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

COX(Cyclooxygenases)	1

本试验旨在研究单次空腹和餐后口服山东诺明康药物研究院有限公司研制、山西复盛公大药厂有限公司生产的阿司匹林肠溶片（100 mg）的药代动力学特征；以Bayer S.p.A持证、Bayer HealthCare Manufacturing S.r.l.生产的阿司匹林肠溶片（Bayaspirin®，100 mg）为参比制剂，比较两制剂中药动学参数Cmax、AUC0-t、AUC0-∞，评价两制剂的人体生物等效性。

[Translation]

The purpose of this study was to study the pharmacokinetic characteristics of aspirin enteric-coated tablets (100 mg) developed by Shandong Nuomingkang Pharmaceutical Research Institute Co., Ltd. and produced by Shanxi Fusheng Gongda Pharmaceutical Factory Co., Ltd. after single fasting and postprandial oral administration; enteric-coated aspirin tablets (Bayaspirin®, 100 mg) certified by Bayer S.p.A. and produced by Bayer HealthCare Manufacturing S.r.l. were used as the reference preparation, and the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two preparations were compared to evaluate the bioequivalence of the two preparations in humans.

Start Date23 Aug 2024

Sponsor / Collaborator

Shanxi Fushenggong Pharmaceutical Group Co., Ltd.

CTR20132349

/ RecruitingPhase 2

注射用盐酸椒苯酮胺对心脏术后心力衰竭患者血流动力学影响的随机、单盲、安慰剂平行对照探索性临床试验

[Translation] A randomized, single-blind, placebo-controlled exploratory clinical trial on the effects of piperphentonamine hydrochloride injection on hemodynamics in patients with heart failure after cardiac surgery

（1）以安慰剂为对照，探索注射用盐酸椒苯酮胺对心脏外科手术后心力衰竭患者血流动力学影响。（2）了解注射用盐酸椒苯酮胺用于心脏外科手术后心力衰竭患者的药代动力学（PK）/药效动力学（PD）特点，进一步评价给药方案。

[Translation]

(1) Using placebo as control, explore the hemodynamic effects of piperphentonamine hydrochloride injection on patients with heart failure after cardiac surgery. (2) Understand the pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of piperphentonamine hydrochloride injection in patients with heart failure after cardiac surgery, and further evaluate the dosing regimen.

Start Date14 Nov 2014

Sponsor / Collaborator

Guangdong Baike Pharmaceutical Co., Ltd.

[+2]

CTR20150140

/ RecruitingPhase 2

注射用盐酸椒苯酮胺对心脏术后心力衰竭患者血流动力学影响的随机、单盲、安慰剂平行对照探索性临床试验

[Translation] A randomized, single-blind, placebo-controlled exploratory clinical trial on the effects of piperphentonamine hydrochloride injection on hemodynamics in patients with heart failure after cardiac surgery

（1）以安慰剂为对照，探索注射用盐酸椒苯酮胺对心脏外科手术后心力衰竭患者血流动力学影响。（2）了解注射用盐酸椒苯酮胺用于心脏外科手术后心力衰竭患者的药代动力学（PK）/药效动力学（PD）特点，进一步评价给药方案。

[Translation]

(1) To explore the hemodynamic effects of piperphentonamine hydrochloride injection on patients with heart failure after cardiac surgery using placebo as control. (2) To understand the pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of piperphentonamine hydrochloride injection in patients with heart failure after cardiac surgery and further evaluate the dosing regimen.

Start Date14 Nov 2014

Sponsor / Collaborator

Guangdong Baike Pharmaceutical Co., Ltd.

[+2]

100 Clinical Results associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.

Login to view more data

100 Deals associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Approved

Login to view more data